Career history of Dean Hakanson
Former positions of Dean Hakanson
| Companies | Position | Start | End |
|---|---|---|---|
| OTONOMY | Chief Tech/Sci/R&D Officer | 2015-03-31 | 2018-01-30 |
| NOVARTIS AG | Corporate Officer/Principal | 2009-06-30 | 2010-04-30 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2007-12-31 | 2009-06-30 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 2005-05-31 | 2007-12-31 |
| GSK PLC | Chief Tech/Sci/R&D Officer | 1997-12-31 | 2004-12-31 |
| National Accounts, Inc. | Corporate Officer/Principal | 1997-12-31 | 2004-12-31 |
Training of Dean Hakanson
| University of Denver | Undergraduate Degree |
| The University of Colorado School of Medicine | Doctorate Degree |
Statistics
International
| United States | 7 |
| United Kingdom | 2 |
| Switzerland | 2 |
Operational
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| GSK PLC | Health Technology |
| NOVARTIS AG | Health Technology |
| Private companies | 3 |
|---|---|
Otonomy, Inc.
 Otonomy, Inc. BiotechnologyHealth Technology Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| National Accounts, Inc. |
- Stock Market
- Insiders
- Dean Hakanson
- Experience
